If you can’t see what you’re looking for, use the search bar below.
OBBI joins BioFIT 2025 to connect with partners in biotech, pharma, and translational research.
With our dual expertise in organoid and EV bioproduction, we offer scalable, standardized solutions for early-stage innovation.
Let’s shape the future of biotherapies—together.
OBBI Showcases EV and Organoid Platforms at SFNano 2025
Daniele Noël, CEO of OBBI, will attend the Innovative Therapies Days 2025 in Besançon—an event bringing together key players in advanced therapies. She will showcase OBBI’s unique expertise in organoid and extracellular vesicle bioproduction, and explore new partnerships to accelerate biotherapeutic innovation.
Montserrat Bosch Grau, Chief Business Officer at OBBI, will attend the 10th Bioproduction Congress in Lyon—the leading European event for biomanufacturing. This will be an opportunity to present OBBI’s expertise in organoid and extracellular vesicle bioproduction and to connect with key academic and industrial partners in advanced biotherapies.
Dr. Danièle Noël, Research Director at IRMB, will be speaking at Biotherapy Days 2026 in Toulouse—the premier gathering for the biotherapy and bioproduction community in Occitanie. As part of her talk, she will present the OBBI initiative, offering valuable visibility to its expertise in organoid and extracellular vesicle bioproduction.
OBBI will be present at Innovative Therapies Days, a key event dedicated to cutting-edge advances in biotherapies and regenerative medicine. We look forward to sharing our expertise and connecting with industry and academic leaders.
OBBI will take part in the upcoming AFSSI Connexions, the annual event for France’s innovative health technology sector. We look forward to showcasing our expertise in the bioproduction of organoids and extracellular vesicles, and to engaging with academic, industrial, and institutional partners across the ecosystem.
